Status:
COMPLETED
Optimizing Quality of Life in Women Living With Metastatic Breast Cancer
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
American Cancer Society, Inc.
Conditions:
Metastatic Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to develop and tailor an intervention program to improve the quality of life in women living with metastatic breast cancer. In the first phase of this study, we conducted ...
Eligibility Criteria
Inclusion
- Patients must be diagnosed with metastatic (stage IV \[M1\]) female breast cancer, via physician diagnosis and confirmed through staff review of electronic medical record (i.e. imaging, surgical pathology reports, etc.).
- Patients must be comfortable speaking English for participation in group sessions.
- Patients must be age ≥ 18 years.
- Patients taking part in the 8 week online pilot trial must have a physician-anticipated life expectancy of \> 6 months.
- Patients must have the ability to understand, and the willingness to sign, a written informed consent prior to registration on study.
Exclusion
- Patients who have severe or impairing psychiatric illness/social situations that would limit compliance with study requirements are not eligible to enroll.
- Patients with early stage/non metastatic breast cancer (Stages I-III) are not eligible to enroll.
Key Trial Info
Start Date :
April 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 8 2021
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04374825
Start Date
April 24 2019
End Date
March 8 2021
Last Update
September 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States, 60611